Aygen, B., Demir, A. M., Gümüş, M., Karabay, O., Kaymakoğlu, S., Köksal, A. Ş., . . . Tabak, F. (2018). Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report. Turk J Gastroenterol.

Aygen, Bilgehan, Ahmet Muzaffer Demir, Mahmut Gümüş, Oğuz Karabay, Sabahattin Kaymakoğlu, Aydın Şeref Köksal, İftihar Köksal, Necati Örmeci, und Fehmi Tabak. "Immunosuppressive Therapy and the Risk of Hepatitis B Reactivation: Consensus Report." Turk J Gastroenterol 2018.

Aygen, Bilgehan, et al. "Immunosuppressive Therapy and the Risk of Hepatitis B Reactivation: Consensus Report." Turk J Gastroenterol 2018.